# HEPLISAV-B

NDC: 50090-4526
Generic name: Hepatitis B Vaccine (Recombinant) Adjuvanted
Labeler / Manufacturer: A-S Medication Solutions
Product type: VACCINE
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20180101

FDA application: BLA125428

## Active ingredients

- HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN: 20 ug/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50090-4526"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-4526